Quantcast

Latest non-surgical treatment Stories

2014-08-22 23:08:06

MetroMD is a leading clinic in America and they specialize PRP Therapy to help people with hip problems and other injuries like ligament damage using non-surgical treatment. (PRWEB)

2014-05-21 08:28:42

NORWALK, Conn., May 21, 2014 /PRNewswire/ -- A newly published peer-reviewed study that examines Stretta(®) therapy,

2014-01-30 23:31:04

RB Spine Center has added Intervertebral Differential Dynamics (IDD) Therapy to its suite of non-surgical treatment options for chronic back and neck conditions. San

2013-07-31 23:34:04

A pair of new studies indicate that most patients with rotator cuff injuries respond well to non-surgical treatment, and a key predictor of who benefits most from physical therapy may simply be

2013-02-06 23:03:43

The Retina Group of New York (RGONY) with offices in Hicksville and Hauppauge, NY, has announced the availability of JETREA® (Ocriplasmin), the first non-surgical treatment for patients with

2010-09-01 00:29:00

LEUVEN, Belgium, September 1, 2010 /PRNewswire-FirstCall/ -- - Data Presented at ASRS Confirm Previous Phase III Findings and Microplasmin's Potential to Transform the Treatment of Retinal Disorders ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of...

2010-07-01 00:27:00

LEUVEN, Belgium, July 1, 2010 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress.

2010-06-07 00:28:00

LEUVEN, Belgium, June 7, 2010 /PRNewswire-FirstCall/ -- - Data Presented Show Microplasmin Cures Approximately 50% of Patients With Macular Hole ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the...

2010-04-20 00:30:00

LEUVEN, Belgium, April 20, 2010 /PRNewswire-FirstCall/ -- - Highly Significant Trial Result (p=0.003) Demonstrates the Potential of Microplasmin in the Treatment of Retinal Disease ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its...


Word of the Day
zill
  • One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.
The word 'zill' comes from a Turkish word meaning "cymbals".
Related